bioAffinity Technologies, Inc. (BIAF)
NASDAQ: BIAF · IEX Real-Time Price · USD
2.020
-0.060 (-2.88%)
At close: Mar 28, 2024, 4:00 PM
2.080
+0.060 (2.97%)
After-hours: Mar 28, 2024, 7:52 PM EDT

bioAffinity Technologies Income Statement

Millions USD. Fiscal year is Jan - Dec.
Year 202220212020
Revenue
000
Cost of Revenue
000
Gross Profit
000
Selling, General & Admin
2.731.070.99
Research & Development
1.141.011.42
Other Operating Expenses
0.150.130.19
Operating Expenses
4.022.212.6
Operating Income
-4.01-2.21-2.6
Interest Expense / Income
2.5310.38
Other Expense / Income
1.613.124.28
Pretax Income
-8.15-6.32-7.27
Income Tax
000
Net Income
-8.15-6.33-7.27
Shares Outstanding (Basic)
433
Shares Outstanding (Diluted)
433
Shares Change
68.17%0.01%-
EPS (Basic)
-1.81-2.36-2.73
EPS (Diluted)
-1.81-2.36-2.73
Free Cash Flow
-4.29-2.05-2.21
Free Cash Flow Per Share
-0.95-0.77-0.83
Gross Margin
90.28%--
Operating Margin
-83511.51%--
Profit Margin
-169771.25%--
Free Cash Flow Margin
-89336.50%--
EBITDA
-5.61-5.32-6.86
EBITDA Margin
-116777.68%--
Depreciation & Amortization
0.0100.02
EBIT
-5.62-5.32-6.88
EBIT Margin
-116989.67%--
Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).